Angela M Lam

Dr. Angela M Lam

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 September 2024 in ACS Infectious Diseases
Verified
Journal Article
Closed access
ETEmily P. Thi
Emily P. Thi
XYXin Ye
Xin Ye
NSNicholas M. Snead
Nicholas M. Snead
ALAmy C. H. Lee
Amy C. H. Lee
HSHolly M. Micolochick Steuer
Holly M. Micolochick Steuer
MSMichael J. Sofia
Michael J. Sofia

21 February 2024 in Viruses
Verified
Journal Article
Open access
PDF file
ALAngela M Lam
Angela M Lam
RDRavi R Dugyala
Ravi R Dugyala
MSMuhammed Sheraz
Muhammed Sheraz
FLFei Liu
Fei Liu
ETEmily P. Thi
Emily P. Thi
ASAnd Michael J Sofia
And Michael J Sofia
HBV RNA destabilizers are a class of small-molecule compounds that target the noncanonical poly(A) RNA polymerases PAPD5 and PAPD7, resulting in HBV RNA degradation and the suppression of viral proteins including the hepatitis B surface antigen (HBsAg). AB-161 is a next-generation HBV RNA destabilizer with potent antiviral activity, inhibiting HBsAg expressed from cccDNA and integrated HBV DNA in HBV cell-based models. AB-161 exhibits broad HBV genotype coverage, maintains activity against variants resistant to nucleoside analogs, and shows additive effects on HBV replication when combined with other classes of HBV inhibitors. In AAV-HBV-transduced mice, the dose-dependent reduction of HBsAg correlated with concentrations of AB-161 in the liver reaching above its effective concentration mediating 90% inhibition (EC90), compared to concentrations in plasma which were substantially below its EC90, indicating that high liver exposure drives antiviral activities. In preclinical 13-week safety studies, minor non-adverse delays in sensory nerve conductance velocity were noted in the high-dose groups in rats and dogs. However, all nerve conduction metrics remained within physiologically normal ranges, with no neurobehavioral or histopathological findings. Despite the improved neurotoxicity profile, microscopic findings associated with male reproductive toxicity were detected in dogs, which subsequently led to the discontinuation of AB-161’s clinical development.

23 April 2024 in ACS Infectious Diseases
Verified
Journal Article
Closed access
EMEugen F. Mesaros
Eugen F. Mesaros
BDBenjamin J. Dugan
Benjamin J. Dugan
MGMin Gao
Min Gao
MSMuhammad Sheraz
Muhammad Sheraz
KMKayleigh McGovern-Gooch
Kayleigh McGovern-Gooch
MSMichael J. Sofia
Michael J. Sofia


8 November 2024 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
DGDimitar Gotchev
Dimitar Gotchev
SCShuai Chen
Shuai Chen
BDBenjamin Dugan
Benjamin Dugan
BDBruce D. Dorsey
Bruce D. Dorsey
XWXu Wang
Xu Wang
MSMichael J. Sofia
Michael J. Sofia

24 September 2024 in Antiviral Research
Verified
Journal Article
Closed access
ALAngela M Lam
Angela M Lam
NMNagraj Mani
Nagraj Mani
AAAndrzej Ardzinski
Andrzej Ardzinski
KSKim Stever
Kim Stever
ACAndrea Cuconati
Andrea Cuconati
MSMichael J. Sofia
Michael J. Sofia